Research partners BASF and CTIBiotech have announced the development of the first 3D bioprinted skin models including immune macrophages. The reconstructed tissue models will be used to test bio-actives for skin care applications.
“Compared to current in vitro methods, the 3D immune bioprinted skin developed with CTIBiotech will allow analysis more in line with human physiology and the immune role of macrophages,” said Sebastian Cadau, 3D tissue engineering specialist at BASF. “That’s how the technology is going to help us accelerate the development of innovative and highly reliable ingredients for the skin care market. Our understanding of an immunocompetent 3D skin provides the basis for developing and testing advanced cosmetic bio-actives for skincare applications.”
“CTIBiotech and BASF have a long history of collaborations on innovative human skin models to advance human skin care,” said Professor Colin McGuckin, Chief Scientific Officer at CTI Biotech. “CTIBiotech hosts a team of world experts for human tissue engineering with 3D bioprinting technology that will strengthen the success of this partnership also in the future.”